Antiplatelet aggregation inhibitor (AAP), a statin, and an antihypertensive drug (Angiotensin-Converting Enzyme inhibitor, ACE, or an angiotensin Receptor Blocker, ARBs) is the Optimal Medical Treatment (OMT) for PAD [5]. This evidence concerns the gene ACE and peripheral arterial disease.